首页> 外文OA文献 >PCV70 Examining Medication Adherence and Low Density Lipoprotein- Cholesterol (LDL-C) Goals among Tricare Beneficiaries Receiving Statin Therapy for Secondary Prevention of Coronary Heart Disease in US Military Treatment Facilities

【2h】

PCV70 Examining Medication Adherence and Low Density Lipoprotein- Cholesterol (LDL-C) Goals among Tricare Beneficiaries Receiving Statin Therapy for Secondary Prevention of Coronary Heart Disease in US Military Treatment Facilities

机译：在美国军事治疗机构接受Statin治疗二级预防冠心病的Tricare受益者中，检查药物依从性和低密度脂蛋白胆固醇（LDL-C）目标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Nwokeji E.; Yarger S.; Trice S.; Chao S.; Gutke G.; Bonnema A.; Selvester R.; Davies W.; Devine J.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: An analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonaL antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57) [J] . DesaiN.R., GiuglianoR.P., ZhouJ., Journal of the American College of Cardiology . 2014,第5期

机译：AMG 145是针对PCSK9的单克隆抗体，可促进高危患者中国家胆固醇教育计划-成人治疗小组III低密度脂蛋白胆固醇目标的实现：来自LAPLACE-TIMI 57试验的分析（使用PCSK9 monoclonaL进行LDL-C评估抗体抑制联合他汀类药物治疗心肌梗塞溶栓57）
2. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. [J] . Athyros VG, Papageorgiou AA, Mercouris BR, Current medical research and opinion . 2002,第4期

机译：用阿托伐他汀治疗达到国家胆固醇教育计划的目标，而不是“预防性”继发冠心病。 GREek阿托伐他汀和冠心病评估（GREACE）研究。
3. An urgent matter-identifying your patients' cardiovascular risk and improving their outcomes. Low-density lipoprotein cholesterol and coronary heart disease: the importance of reaching target goals with statin therapy. [J] . Lewis SJ The Journal of family practice . 2009,第11Suppla期

机译：紧急事件，可识别患者的心血管风险并改善其结果。低密度脂蛋白胆固醇和冠心病：使用他汀类药物疗法达到目标的重要性。
4. Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins [O] . Kathleen M. Fox, Ming-Hui Tai, Karel Kostev, -1

机译：接受高强度或中等强度他汀类药物的患者的治疗模式和低密度脂蛋白胆固醇（LDL-C）目标达成
5. PCV67 EXAMINING MEDICATION ADHERENCE AMONG TRICARE BENEFICIARIES RECEIVING STATIN THERAPY FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MILITARY TREATMENT FACILITIES IN THE UNITED STATES [O] . E. Nwokeji, S. Yarger, S. Trice, 2011

机译：PCV67检查特理受益者中的药物遵守，接受他汀类药物治疗的二级预防冠心病在美国军事治疗设施中的冠心病

PCV70 Examining Medication Adherence and Low Density Lipoprotein- Cholesterol (LDL-C) Goals among Tricare Beneficiaries Receiving Statin Therapy for Secondary Prevention of Coronary Heart Disease in US Military Treatment Facilities

著录项

相似文献

相关主题

期刊订阅